In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb alcohol and opioid addiction. Published in the journal Addiction, this new study saw researchers from Loyola University Chicago sift through more than 1.

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down substance use cravings too.

Researchers from Loyola University Chicago are adding to the growing evidence suggesting that medications like Ozempic can treat substance abuse. Ozempic — which mimics the body’s naturally occurring GLP-1 hormone to make people feel full and eat less — treats diabetes and can spur weight loss.

Diet and diabetes drugs like Ozempic and Mounjaro could also help people struggling with alcohol and opioid abuse, according to a new study.

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and fullness,

A new study published today in Addiction suggests that Ozempic and similar medications may be able to help with treatment for opioid and alcohol use disorders.

The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

Ozempic and similar products cut opioid and alcohol abuse by up to half, according to research that adds to evidence of the hugely popular blockbuster drugs’ broad potential beyond tackling obesity and diabetes.